| For: | Lian LY, Huang CX, Chen QF, Zhou XD. Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution. World J Cardiol 2025; 17(2): 103845 [PMID: 40061276 DOI: 10.4330/wjc.v17.i2.103845] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i2/103845.htm |
| Number | Citing Articles |
| 1 |
Antonio Liguori, Valentin Calvez, Lucrezia Petrucci, Fabrizio Termite, Lidia Tomasello, Angela Sciarra, Simone Varca, Antonio Gasbarrini, Maurizio Pompili, Luca Miele. MASLD Beyond the Liver: A Systemic Driver of Cardiovascular, Renal, and Oncologic Risk. Current Hepatology Reports 2026; 25(1) doi: 10.1007/s11901-026-00732-y
|
| 2 |
Nikolaos-Iason Tepetes, Charalampos Filippatos, Stavros Athanasopoulos, Christina Konstantaki, Panagiota Batziou, Angelos Soranidis, Peggy Kostakou, Kimon Stamatelopoulos, Alexandros Briasoulis. Improved Survival With Sodium–Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Heart Failure With Preserved Ejection Fraction and Metabolic Dysfunction-Associated Steatotic Liver Disease. American Journal of Therapeutics 2026; doi: 10.1097/MJT.0000000000002139
|
| 3 |
Annalisa Cespiati, Jörn M Schattenberg. The spectrum of steatotic liver disease (SLD) in cardiology: time to screen for coexisting liver disease. European Journal of Heart Failure 2026; doi: 10.1093/ejhf/xuag128
|
| 4 |
Hüseyin Ali Öztürk, Erdinc Gulumsek, Dilan Damla Ozturk, Fatih Necip Arıcı, Cigdem Erhan, Bektaş Işık, Mehmet Can Erişen, Berçem Berent Kaya, Ugur Can Izlimek, Cahit Dincer, Ahmet Gazi Mustan, Çisem Yılmaz, Tayyibe Saler, Hilmi Erdem Sümbül. Evaluation of Cardiorenal Metabolic Syndrome in Patients with Heart Failure with Preserved Ejection Fraction. How Aware Are We?. Sakarya Medical Journal 2025; 15(3) doi: 10.31832/smj.1684457
|
| 5 |
Yumeng Jia, Wenhui Niu, Lu Liu, Qun Zhang, Dingwei Li, Tangyu Dai, Jie Du, Lei Wang. Succinate–GPR91 signaling promotes cardiomyocyte metabolic reprogramming and NAD+ production to alleviate HFpEF. Cardiovascular Diabetology 2025; 25(1) doi: 10.1186/s12933-025-03030-x
|
| 6 |
Jeongin Lee, Sangwook Cheon, Eun Seok Kang, Jihun Song, Hye Jun Kim, Taeho Kwak, Seokjin Kong, Jin-Hyun Park, Minjeong Kang, Seohui Jang, Yihyun Kim, Jinhyeok Choi, Hwamin Lee, Jaewon Khil, Seogsong Jeong. Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults. European Journal of Heart Failure 2026; 28(2) doi: 10.1093/ejhf/xuag036
|